Your shopping cart is currently empty

Prinoxodan is a potent phosphodiesterase 3 (PDE3) inhibitor. It exerts cardiotonic and vasodilatory effects by increasing intracellular cAMP levels, used for heart failure and cardiovascular research.


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $61 | - | In Stock | |
| 5 mg | $147 | - | In Stock | |
| 10 mg | $243 | - | In Stock | |
| 25 mg | $513 | - | In Stock | |
| 50 mg | $793 | - | In Stock |
| Description | Prinoxodan is a potent phosphodiesterase 3 (PDE3) inhibitor. It exerts cardiotonic and vasodilatory effects by increasing intracellular cAMP levels, used for heart failure and cardiovascular research. |
| In vitro | Prinoxodan dose-dependently (5 nmol-5 umol) increases myocardial contractility in isolated guinea pig hearts [1]. |
| In vivo | Prinoxodan (30-300 ug/kg i.v. or 0.3 mg/kg p.o.) significantly enhances myocardial contractility and reduces peripheral resistance in dogs [2]. |
| Synonyms | RGW2938 |
| Molecular Weight | 258.28 |
| Formula | C13H14N4O2 |
| Cas No. | 111786-07-3 |
| Smiles | O=C1NC=2C=CC(=CC2CN1C)C3=NNC(=O)CC3 |
| Relative Density. | 1.47 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol: < 1 mg/mL (insoluble) |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.